Axe Compute Inc. (AGPU) Stock

Axe Compute Inc. (AGPU) is a Financials stock trading at $10.24 (as of 2026-08-21), with a market capitalization of $106.54M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Axe Compute Inc. uses AI to support cancer drug discovery and development and operates through two segments. In Pittsburgh, it applies AI using its tumor-sample biobank and develops proprietary 3D culture models; in Eagan, it manufactures the FDA-cleared STREAMWAY System and related products for automated medical fluid waste management and patient-to-drain disposal.

Understand Axe Compute Inc.: how it makes money

Axe Compute applies AI to support cancer therapy discovery and development, and it also produces the FDA-cleared STREAMWAY System for automated medical fluid waste management, monetizing through AI-enabled compute and related services plus STREAMWAY system and associated products.

The profit model is driven by monetizing two distinct capabilities, AI-based services built on a proprietary biobank and 3D culture models (Pittsburgh), and the STREAMWAY System and related products for automated medical fluid waste management (Eagan).

Revenue by segment (latest quarter)
Pittsburgh$0.0B
Eagan$0.0B

Business quality (Weak): Latest-quarter reported revenue is 0.0B, and the reported gross and operating margins are deeply negative, so period-over-period financial interpretation is limited.

Bull case

  • Proprietary AI inputs for therapy development: The Pittsburgh segment uses a proprietary biobank of 150,000+ tumor samples and creates proprietary 3D culture models used in drug development.
  • Regulated, FDA-cleared product offering: The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management.
  • Measured go-to-market footprint: The company reports global location coverage of 200 locations and coverage in 93 countries.

Bear case

  • No reported revenue in the latest quarter: Reported revenue for the period ended 2026-03-31 is 0.0B, which limits the ability to judge current monetization.
  • Operating losses indicated by margin metrics: Reported gross margin and operating margin percentages are highly negative in the latest quarter.
  • Pipeline needs conversion into paying activity: The available operating metrics highlight Customer Pipeline and Enterprise Customer Count, but there is no disclosed linkage here showing how that pipeline translates into revenue in the latest quarter.
Valuation — source: SEC EDGAR (first-party)
Price$10.24
Market Cap$106.54M
Price / Book3.13
Price / Sales32.39
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$125284.00
Net Margin-186053.4%
Revenue Growth (YoY)-92.3%
EPS Growth (YoY)476.3%
Financial Health — source: SEC EDGAR
Altman Z-Score-14.78 (distress)
Valuation vs Sector & Industry
Sector P/E (Financials)15.1
Industry P/E (Banking)13.0
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderDiametric Capital, LP ($221807.00)
Institutional Holders Tracked10
Company
SectorFinancials
IndustryBanking
CEOJoshua Blacher
Employees23
CountryUS
IPO Date2010-05-03

Related Companies (Business model: Crypto Exchange / Custody / Staking; 8 closest by market cap; US-domiciled)

  • Solana Company (HSDT)
  • DeFi Development Corp. (DFDV)
  • SUI Group Holdings Limited (SUIG)
  • BTCS Inc. (BTCS)
  • FORUM MARKETS Inc (FRMM)
  • Exodus Movement, Inc. (EXOD)
  • Brag House Holdings, Inc. (TBH)
  • Upexi, Inc. (UPXI)
AGPU earnings history · AGPU institutional & insider holders · AGPU KPIs & operating metrics · AGPU financials · AGPU investor presentations & press releases · AGPU SEC filings · AGPU peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-21.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.